RFP

South Korea’s Research Investment for Global Health Technology (RIGHT) Fund launched its sixth RFP on Monday: a new Technical Accelerator Award granting up to $440,000 (per project, for up to one year) for “original and innovative concepts” that tackle endemic and emerging infectious diseases in developing countries.

Applicants must include at least one Korean entity. Proposals for vaccines and therapeutics are due by April 9 and for diagnostics and digital health by April 30.

South Korea’s Research Investment for Global Health Technology (RIGHT) Fund launched a new RFP this week, awarding up to $452,000 (per grant) for early-stage vaccines, therapeutics, diagnostics and digital health technology projects tackling infectious diseases in developing countries.

Applicants must include at least one Korean entity and submit their proposals by December 18. RIGHT Fund has so far invested $25.3 million in 22 R&D projects since its launch, according to the press…

South Korea’s Research Investment for Global Health Technology (RIGHT) Fund announced this week an additional $14.9 million for 17 infectious disease projects, including Covid-19 vaccines and technology.

The fund said it has now committed approximately one-third of its investment portfolio to respiratory infections since its launch in 2018.

The fund’s RFP for R&D projects is open through July 6.

Japan’s nonprofit Global Health Innovative Technology Fund (GHIT Fund) launched a new RFP this week calling for novel drugs, diagnostics and vaccines for malaria, tuberculosis and neglected tropical diseases to “address health needs in the developing world or fill a gap in global health technologies for infectious diseases.”

Applications are due July 29 and full proposals August 17.